Here are relevant reports on : us-almond-market
-
Depth of Anesthesia Monitoring Market by Product (Devices, Consumables), Device (Module, Standalone), Mode of Purchase (Group Purchasing Organization, Direct Purchase), End User (Hospitals, Ambulatory Surgery Center, Clinic) - US Forecast to 2024
The depth of anesthesia monitoring market size is projected to reach USD 170 million by 2024, at a CAGR of 3.2%. The growth of this market is primarily driven by the growing patient pool in hospitals in the US and the increasing number of surgeries. However, the high installation and maintenance costs of depth of anesthesia monitoring devices are expected to restrain the growth of this market in the coming years. The prominent players operating in this market include Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Medtronic Public Limited Company (Ireland), GE Healthcare (US), Mennen Medical Ltd. (Israel), Masimo Corporation (US), and Philips Healthcare (Netherlands).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Heart Health Ingredients Market By Types (Phtosterols, Omega-3 PUFA, Beta-Glucan, U.S. Soy Ingredients, others) By Geography (NA, APAC, Europe & ROW)
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
US Centrifugal Pump Market by Type (Overhung Impeller, Between Bearing, Vertically Suspended), Operation Type (Electrical, Hydraulic, Air-driven), Stage (Single-stage, Multistage), End User (Industrial, Commercial & Residential) – Forecast to 2030
The US centrifugal pump market is projected to reach USD 9.85 billion by 2030 from an estimated USD 7.16 billion in 2025, at a CAGR of 6.6% during the forecast period. Leading manufacturers such as Xylem Inc., Flowserve Corp., ITT Corp., Grundfos, and KSB SE & Co. KGaA have an expansive presence throughout the US, including significant operations for manufacturing, distribution, and after-sales services.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Sunitinib Malate Market Forecast for Pancreatic Cancer, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan) - Global Forecast to 2021
The sunitinib malate market size for pancreatic cancer is projected to grow at a CAGR of 13.9%. Over the years, the sunitinib malate market for pancreatic cancer has observed steady growth and this trend is expected to continue in the coming years. This is primarily because the market is witnessing increasing adoption of drug therapy for the treatment of pancreatic cancer. This report categorizes patients with pancreatic neuroendocrine tumors (pNET) based on three different stages, namely, localized, advanced, and distant.
- Published: May 2016
- Price: $ 4950
- TOC Available:
-
US Radiation Detection, Monitoring, and Safety Market by Product (Personal & Area Dosimeter, Material & Full Body Monitor), Component (GM Counter, Diamond Detector, Scintillator), Application (Nuclear Plant, MFG, ENV, Healthcare, Defense) - Forecast to 2031
The US Radiation Detection, Monitoring, and Safety market, valued at USD1.65 billion in 2025, stood at USD1.78 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of USD2.65 billion by the end of the period. The US market for radiation detection, monitoring, and safety is currently experiencing growth. The increased use of radiation in medical diagnostics, nuclear energy, and various industrial applications is heightening the need for precise monitoring.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US Veterinary Diagnostics Market by Application (Infectious, Bacterial, Endocrine), Technology (Immunodiagnostic, PCR, ELISA, Lateral Flow), Product (Consumables, Instruments), Animal Type (Dog, Cat, Cattle), End User (POC, Veterinary Labs) – Forecast to 2031
The US veterinary diagnostics market, valued at USD2.22 billion in 2025, stood at USD2.41 billion in 2026 and is projected to advance at a resilient CAGR of 9.1% from 2026 to 2031, culminating in a forecasted valuation of USD3.74 billion by the end of the period.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Heart Health Ingredients Market By Types (Phtosterols, Omega-3 PUFA, Beta-Glucan, U.S. Soy Ingredients, others) By Geography (NA, APAC, Europe & ROW)
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
US Chromatography Accessories & Consumables Market By Product (Column, Autosampler, Tubing, Detector, Fraction Collector), Technology (HPLC, UPLC, LPLC, GC), End User (Pharma-biopharma, F&B, CROs, Clinical labs, Petrochemical, Env Labs) - Forecast to 2031
The US chromatography accessories & consumables market, valued at US$2.08 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.7% from 2025 to 2031, culminating in a forecasted valuation of US$3.50 billion by the end of the period. The market is primarily driven by the rapid expansion of pharmaceutical and biotechnology research, fueled by rising drug discovery programs, biosimilar development, and increasing investments in biologics manufacturing.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US eGRC Market by Solution (Risk Management, Compliance Management, Audit Management, Policy Management, Privacy Management), Service (Professional, Managed), Business Function (Legal, Finance, Operations), Vertical (BFSI, Healthcare) - Forecast to 2030
The enterprise, governance, risk, and compliance (eGRC) market size in the US is projected to grow from USD 5.45 billion in 2025 to USD 10.17 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 13.3% . The Key Players IBM (US), Archer Technologies (US), Microsoft (US), Oracle (US), SAS Institute (US), ServiceNow (US), FIS (US), LexisNexis (US), MetricStream (US), Riskonnect (US), Navex Global (US), OneTrust (US), LogicManager (US), Allgress (US), Onspring (US), Optimiso (US), Comensure (US), LogicGate (US), VComply (US), and SmartSuite (US) are the key players in the eGRC market in the US.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US Interventional Cardiology Devices Market by Type (Stents, Balloons, Structural Heart, Angio Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration, Guidewire, Introducer Sheaths), End User (Hospitals, Cardiac Centers) - Forecast to 2031
The US interventional cardiology devices market, valued at USD 12.09 billion in 2025, stood at USD 12.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 17.75 billion by the end of the period. The market is driven by the increasing number of cases of heart and blood vessel diseases, especially coronary artery disease and heart valve disorders, and the aging population.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50